Registry following melanoma patients in Spain to study factors affecting outcome
Records melanoma patients in Spain to study factors linked to how the disease progresses.
Plain-language title generated from the registry record
Registry title: Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
Key facts
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Las Palmas, León, Madrid, Oviedo, Palma de Mallorca, Pontevedra, Santa Cruz de Tenerife, Seville, Valencia, and Zaragoza, SpainSee the 21 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for people newly diagnosed with invasive primary melanoma of the skin at the taking-part centres. Data is collected without any change in care.
- Sex
- All sexes can join.
- Disease stage
- Invasive primary melanoma of the skin.
Main reasons for not taking part
- In-situ melanomas
- Melanomas that are not of the skin
- Metastatic melanoma with unknown primary site
Read by machine on 12 November 2026.
Where in Spain
- Complexo Hospitalario Universitario de A CoruñaA Coruña, SpainContact: Sabela ParadelaNot yet recruiting
- Hospital Universitari Germans Trias i PujolBadalona, SpainContact: Aram Boada, MDTaking people
- Hospital ClinicBarcelona, SpainContact: Susana Puig, PhDTaking people
- Hospital San Juan de DiosCórdoba, SpainContact: Antonio Tejera, PhDTaking people
- Hospital Universitario De Gran Canaria Dr. NegrinLas Palmas, SpainContact: Elena Castro, MDTaking people
- Complejo Asistencial Universitario de LeonLeón, SpainContact: Elia Samaniego González, MDTaking people
- Clínica Dermatológica InternacionalMadrid, SpainContact: Pedro Rodríguez JiménezNot yet recruiting
- Clínica Universitaria de Navarra (sede de Madrid)Madrid, SpainContact: Alejandra Tomás VelázquezTaking people
- Hospital Clínico San CarlosMadrid, SpainContact: Alberto Conde Taboada, PhDTaking people
- Hospital La PazMadrid, SpainContact: Ander MayorTaking people
- Hospital Puerta de Hierro MajadahondaMadrid, SpainContact: Gastón RoustanNot yet recruiting
- Ruber InternacionalMadrid, SpainContact: Pedro Rodríguez JiménezNot yet recruiting
- Hospital Central de AsturiasOviedo, SpainContact: Cayetana MaldonadoTaking people
- Hospital Son LlàtzerPalma de Mallorca, SpainContact: Rosa TabernerTaking people
- Complexo Hospitalario Universitario de PontevedraPontevedra, SpainContact: Ángeles FlórezNot yet recruiting
- H.U. Nuestra Señora de la CandelariaSanta Cruz de Tenerife, SpainContact: Ricardo Fernandez de Misa CabreraTaking people
- Hospital Universitario Virgen Macarena de SevillaSeville, SpainContact: Lara FerrándizTaking people
- Quirón Salud SevillaSeville, SpainContact: Tomás Toledo PastranaNot yet recruiting
- Hospital La FeValencia, SpainContact: Rafael BotellaNot yet recruiting
- Instituto Valenciano de OncologiaValencia, SpainContact: Eduardo Nagore Enguidanos, PhDTaking people
- Hospital Miguel ServetZaragoza, SpainContact: Yolanda GilaberteNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundación Academia Española de Dermatología
- Trial code
- NCT05673681
- Record updated
- 9 January 2023
- Original description
The goal of this patient registry is to describe risk factors for bad prognosis of melanoma in Spain. The main questions it aims to answer are:Read full original descriptionShow less
Registro de Melanoma de la AEDV
The goal of this patient registry is to describe risk factors for bad prognosis of melanoma in Spain. The main questions it aims to answer are:
* To describe socioeconomical individual risk factors associated with melanoma prognosis, such as gender, residence area or socioeconomic level. * To describe potentially modifiable characteristics of health care associated with prognosis, such as waiting times, type of centre that makes the diagnosis or use of teledermatology Participants data will be gathered for analysis, without any change in the way that they are being treated.
Inclusion: All consecutive patients with a diagnosis of invasive primary cutaneous melanoma in participating centres.
Exclusion: In-situ melanomas; non-cutaneous melanomas,; metastatic melanoma with unknown primary site.